Which lipid-lowering medication is considered safe for use during pregnancy?

The use of LDL-lowering lifestyle modifications during pregnancy is considered safe because these modifications include dietary changes, physical activity, and behavioral adjustments that do not involve pharmacological interventions. These lifestyle changes can effectively help manage cholesterol levels without posing risks to the developing fetus.

In contrast, statins and fibrates are associated with potential risks during pregnancy. Statins, for example, are contraindicated due to concerns about teratogenic effects, which could harm fetal development. Fibrates also lack adequate safety data in pregnant populations, which makes them less favorable.

Omega-3 fatty acids, while often regarded as beneficial for heart health, have insufficient evidence of safety during pregnancy when used as a treatment for lipid lowering. Therefore, recommended practices focus on lifestyle modifications that are safe and beneficial throughout the gestational period.